Poster Tours
Digital Poster screens are located in Hall 3
Guided Poster Tours take place as follows:
Poster Session 1: Wed 6, 1145
Screen 1: Epilepsy
Screen 2: Headache
Screen 3: MS/Inflammatory
Screen 4: Muscle / NMJ / Peripheral Nerve
Screen 5: Movement Disorders
Poster Session 2: Thur 7, 1230
Screen 6: Cognitive
Screen 7: Vascular
Screen 8: Acute Neurology / Oncology
Screen 9: QST
Screen 10: Infection/Encephalitis/Functional
Bursaries & Prizes
Bursaries
Bursaries of £50 are available for up to 100 early career researchers who are lead authors of abstracts accepted for the 2026 meeting. Apply for a bursary when you submit your abstract. If your award is successful, £50 will be credited back onto your card.
Prizes
There are prizes on offer for posters, platforms and case presentations from trainees and students. The presentations will be scored by delegates and the winners will be announced during the final session of the meeting on Friday 8 May.
Prize | 2026 | |
|---|---|---|
Charles Symonds Prize | Top Platform | £500 |
Charles Symonds Prize | Top Poster | £400 |
Practical Neurology Prize | Case Presentation Competition | £500 |
Wed 6 May • 1145 - 1245
Screen 1: Epilepsy
1 Sarah Wrigley: Cryptogenic New Onset Refractory Status Epilepticus in an adult: Clinical pearls and pitfalls of management
2 Hannah Eaton: Patients who do not attend their appointment for assessment after a first suspected seizure
3 Vivienne Evans: Diagnostic Value and Utilisation of Home Video in Epilepsy Care Within a Tertiary Neurology Department
4 Sam Amin: Fenfluramine in CDKL5 Deficiency Disorder: Primary Efficacy and Safety Results From a Phase 3 Study
5 Kabir Josan: Attendance rates for epilepsy appointments in relation to deprivation: comparison of face-to-face and virtual appointments.
6 William Clark: Vagus nerve stimulation induced reflex seizures
7 Aidan Whitehead: Occipital Lobe Status Epilepticus Secondary to Non-Ketotic Hyperglycaemia
8 Emily Pegg: An Audit of Women’s Health Counselling in the Epilepsy Clinic
9 Alexander Grundmann: The Public Health and Economic impact of SUDEP: A Hamiltonian Markov Chain Monte Carlo Model
10 Lavindren Luke Panneerchelvam: Newcastle’s First Experience With EASEE® Epicranial Neuromodulation For Drug-Refractory Focal Epilepsy: A Two-Patient Case Series.
Screen 2: Headache
11 Dwij Mehta: Evaluating the role of non-targeted epidural blood patch in the management of spontaneous intracranial hypotension.
12 Stephanie Williams: Intracranial Hypertension – A clinical pearl in consulting haematology patients
14 Amy Mardle: Perinatal use of corticosteroid containing greater occipital nerve injections for primary headache disorders
15 Benjamin Edmans: Unusual Headache Case Reports: On the potential aetiologies of Hypnogogic and Shower Headaches
16 Md Tariqul Islam: Intracranial Hypertension Likely Secondary to Testosterone Intake in a Patient Undergoing Female-to-Male Transition
17 Richard Oguntoye: Secondary Headaches Due to Dural Arteriovenous Fistulas: A Mimic of Cluster Headache
18 Andreas Yiangou: Identifying microRNA markers in idiopathic intracranial hypertension: a pilot study.
19 Rudramun Gopal: Trigeminal Neuralgia as the Sentinel Presentation of Chiari I–Related Syringomyelia in an Adolescent
20 Dwij Mehta: Evaluating the prevalence and characteristics of orthostatic headaches in postural tachycardia syndrome
Screen 3: MS/Inflammatory
21 Gavin Giovannoni: Ocrelizumab vs placebo in PPMS: efficacy and safety results of the Phase IIIb ORATORIO-HAND study
22 Sean Apap Mangion: Baseline Patient-Reported Outcomes Predict Clinical Progression in Progressive MS: An MS-SMART Post-Hoc Analysis
23 Ashraf Hunedy: Recurrent Area Postrema Syndrome in a Suspected Seronegative NMOSD: An 18-Year Follow-Up Case
24 Prateek Choudhary: SHIELD: Surveillance of health and infections in MS linked to disease modifying therapies
25 Piri Ananthavarathan: Changes in pre-lesional normal-appearing white matter are detectable 16 years before lesion formation in MS
26 Dashne Omar: A Scoping Review of Neurosarcoidosis: The changing treatment land-scape and its clinical determinants.
27 Rajesh Ambati: From Auricular Inflammation to Myelitis: The Neurological Spectrum of Relapsing Polychondritis
28 Aneliya Takova: First presentation with Optic neuritis does not result in delayed DMT initiation in MS
29 Michelle Richardson: Acute Cerebellitis Following Semaglutide Use
30 Edward Nicholas: Switching to biosimilars in multiple sclerosis: patient experiences on natalizumab
Screen 4: Muscle / NMJ / Peripheral Nerve
31 Rajesh Ambati: A Myositic Mirage: When Rheumatoid Vasculitis Mimics Inflammatory Myopathy
32 Bhairavi Wijayendran: Myasthenia Gravis in Pregnancy: Outcomes from a Tertiary Centre Cohort
33 Viva Levee: Establishing a Tofersen service for SOD1-ALS:Audit of single centre experience at St Georges Hospital, London
34 Murva Asad: Progressive muscle MRI changes in periodic paralysis: a longitudinal cohort study
35 Rebecca Cooper: Acquired Multiple Acyl CoA Deficiency: 2 case reports
36 Lucy Manley: NF2-Schwannomatosis Associated Polyneuropathy: A Single Retro-spective Case Series
37 Li Ying Tay: Monomelic weakness and numbness: A case of radiotherapy-induced Focal CIDP
38 Michael Lunn: Acquired Vitamin B6 Deficiency in POEMS: A Marker of
Disease Activity and Cause of Neuropathy?
39 Devan Mair: From IVIg Optimisation to Home-Based Immunoglobulin Therapy
40 Muhammed Ameen Noushad: Optimising CIDP Care: A systematic review of the evidence supporting structured Immunoglobulin withdrawal trials
Screen 5: Movement Disorders
41 Ashmit Bhardwaj: Revisiting Laterality in Drug-Induced Parkinsonism: Challenging the Symmetry Paradigm in a 10-Year Tertiary Cohort
42 Kinan Muhammed: Real-World Multicentre Smartphone Based Tracking for Parkinson’s Disease
43 Julia Greenland: Sex-dependent differences in the immune response to treatment with azathioprine in Parkinson’s disease
44 Akshayaa Kumar Aggarawal: Atypical Anatomy, Classic Movements: Hemichorea–Hemiballismus from Centrum Semiovale Infarct
45 Viveka Biswas: Spino-cerebellar ataxia 27B with multi-system atrophy-like presenta-tion
46 Yasaman Mousavi: The Effect of Foslevodopa/Foscarbidopa Treatment on Nonmotor Symptom Burden in Advanced Parkinson’s Disease
47 Paola Giunti: Omaveloxolone in Friedreich Ataxia: 4-Year Efficacy and Safety Data From MOXIe Extension
48 Vanessa Ng: Investigating Motion Capture Movement Metrics for Disease Progression Biomarkers in Progressive Supranuclear Palsy patients.
49 George Krilis: Heat Map Visualisation of Motor States in People with Parkinson’s Disease Treated with Foscarbidopa/Foslevodopa
50 Jacob Mistry: Dual pathology in late-onset episodic ataxia: SCA27B with co-existing parkinsonian degeneration
Thur 7 May • 1230 - 1330
Screen 6: Cognitive
51 Michael Rushworth: A 48-Month Analysis of the Lecanemab Clarity AD Open-Label Extension in APOE4 Non-Carriers and Heterozygotes
52 Zhilin Jiang: Autonomic involvement across the spectrum of genetic prion diseases
53 John Erskien: Neurodegenerative outcomes in antidepressant-associated REM sleep behaviour disorder
54 Arthur Stacey: Validating Referral Triage Criteria for Functional Cognitive Symptoms in a Cognitive Neurology Clinic
55 Anastasia Mirza-Davies: Night-time activity detected by contactless remote monitor-ing is associated with falls in dementia
56 Sanjida Chowdhury: When the Past Catches Up: Iatrogenic Creutzfeldt–Jakob Dis-ease With a 39-Year Incubation Period
57 Ben Jacobs: The contribution of Apoliproprotein E genetic variation to dementia risk in British South Asians
58 Rebecca Kuruvilla: A Real-World UK Experience of Disease-Modifying Therapy in Alz-heimer’s Disease
59 Hin Kwan Jeroan Yip: Validating a Clinical Assessment of Working Allocentric Spatial Memory
60 Charlie Nye: Relationships between sleep actigraphy, subjective sleep, fatigue, and cognition in older adults in Northern Tanzania
Screen 7: Vascular
61 Nushrat Jahan: A case of Moyamoya syndrome associated with Grave’s disease
62 Swetha Giridharan Menon: Challenging case of Bilateral Opercular syndrome
63 Amit Chowdhury: Enhancing Secondary Stroke Prevention: An Audit at Derriford Hospital, Plymouth
64 Angela Yan: A rare (but treatable) cause of both ischaemic and haemorrhagic stroke in a young adulta
65 Lupei Cai: Multiple simultaneous acute infarcts as a presentation of CADASIL, and its association with recent infection
66 Sashini Mariathasan: What are we missing? A decade of auditory symptoms in the TIA clinic
67 Sashini Mariathasan: A Decade of Vestibular Presentations to TIA Service: A High-Risk Cerebrovascular Presentation
68 Obioma Orazulume: The Stroke Unit as a Portal for Primary Prevention: Screening At-Risk Relatives
69 Ariel George: Immune effector cell-associated neurotoxicity syndrome (ICANS) with intracerebral haemorrhage – a case report.
70 Molly Yeo: Striking clinico-radiological dissociation in hypertensive brainstem en-cephalopathy complicated by delayed brainstem haemorrhage
Screen 8: Acute / Oncology
71 Linda Lei: Rapid Deterioration on ITU: A Devastating Combination of Genetics and a Viral Infection
72 Musab Eltahir: Labrune syndrome without cysts: a genetically confirmed case highlighting diagnostic challenges.
73 Aiknaath Jain: Delayed Post-Hypoxic Leukoencephalopathy after Overdose: A Case of Biphasic Neurologic Decline with Unexpected Recovery
74 Niamh Oldfield: Increasing use of immune-checkpoint inhibitors: need for increased awareness, and implications for service development
75 Sabbiha Majumder: A rare cause of bilateral arm weakness in an older adult
76 Vaishnavi Sharma: Development and Validation of the NOVA Score for Surgical Triage in Metastatic Spinal Cord Compression
77 Vaishnavi Sharma: Human Versus Machine: Comparative Accuracy of Survival Prediction in Metastatic Spinal Cord Compression
78 Marie Ryan: Beyond Infection and Infiltration: Autoinflammatory Neurological Disease in Chronic Myelomonocytic Leukaemia
79 Mai Elrayes: Dysarthria and Dysphagia: When a Tongue Tumour Mimics Central Causes
80 Amelia Panavila: Gut Instinct: When Gastrointestinal Symptoms Signal a Neurologi-cal Storm
Screen 9: Quality, Service & Training
81 Teona Serafimova: Immunoglobulin G reduction with different plasma exchange regimes in autoimmune neurological conditions
82 Hollie Gibbins: Drop the ‘Drop Test’ for Lower Limb Tone: Assessing Inaccuracies in Internet Education
83 Swetha Giridharan Menon: Efficacy of Botox Injections for Refractory Trigeminal Neuralgia
84 Asha Bissessar: Development of an acute dizziness pathway for management of patients in Southwest London
85 Ashni Khetarpal: The challenges of acute neuro-ophthalmology presentations: Standardised pathways, early OCT and SDEC may be the answer
86 Anuriti Aojula: Utility of non-mydriatic fundus photography in same day emergency care (SDEC): a pilot study
87 Raluca Negulescu: Improving medical students’ knowledge and confidence in diagnosing Functional Neurological Disorders (FND)
88 Camille Carroll: Join Parkinson’s Research (JPR@Research+Me): A UK-wide registry to support clinical trial recruitment in Parkinson’s disease
89 Alex Hayes: Socioeconomic health inequalities in access to shunting for Normal Pressure Hydrocephalus at two regional centres
90 Georgia Ferguson: Focused Ultrasound Thalamotomy: Post-procedural Side Effect Profile from 4 years of Treatments in Scotland
Screen 10: Infection/Encephalitis/Functional
91 Yen Wen Phong: Extensive Spinal Subdural Collections in MSSA Meningitis: An Uncommon Cause of Acute Paraparesis
92 Jafor Sadeque: Diagnostic accuracy and management of encephalitis in a secondary care setting – a local audit
93 Kyaw Soe Thein: Diagnostic Convergence: Alpha-Enolase and Anti-TPO Antibodies in Autoimmune Encephalopathy
94 Michelle Richardson: Unmasking Late-Onset Rasmussen’s Encephalitis
95 Jack Tallentire: Functional Neurological Disorder (FND) in Primary Care: Survey of General Practitioners’ Knowledge, Attitudes and Practices
96 Owen Pickrell: Functional/Dissociative Seizures (FDS) in Wales, a retrospective study using routinely collected data
97 Andrew Jones: Altered postural control in PPPD: evidence for maladaptive mechanisms from motion capture posturography
98 Andrew Whitfield: Objective measurement of Hoover’s sign in healthy controls and patients with functional neurological disorder
99 Antoniette Marie Guerrero: Migraine prevalence and management in functional neurological disorder: a retrospective audit
100 Benjamin Sacks: A technique for inducing hoovers sign in healthy controls: mechanistic insights into functional neurological symptoms
Email the ABN
Email the Conference Team
abn@phproductionservices.co.uk
Call the ABN
44 (0) 20 7405 4060